Window of Opportunity Trial of Neoadjuvant Olaparib and Durvalumab for Triple Negative or Low ER+ Breast Cancer
Clinical trial NCT03594396 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03594396
- Sponsor
- Seoul National University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-29
- Primary completion
- 2025-12-31
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.